All
Botulinum toxin treatments safe, but adverse event lawsuits on the rise
July 1st 2013Botulinum toxin treatments are considered to be safe, particularly when used for on-label indications and in the cosmetic arena. A recent study finds, however, that lawsuits associated with botulinum toxin treatments are on the rise, underscoring the need for physicians to be wary and “handle with care.”
Many potential indications for botulinum toxin formulations have yet to be realized
July 1st 2013The emergence of new formulations of botulinum toxin and other neuromodulators in the pipeline awaiting approval by the Food and Drug Administration signal a need for clinicians to stay abreast of the various uses and potential adverse events.
Curbside consultations have value, are free of many administrative encumbrances
July 1st 2013My hospital requires documentation of how I spend my time, tabulated in hours per week, for one representative week every month, an exercise related to CMS funding. The time can be allotted among only three mutually exclusive categories: “Hospital Activities,” “Teaching Activities” and “Patient Care.” My university also quantifies my productivity in RVUs, clinical charges, grants submitted, grants awarded and publications.
Clarifying restrictive covenants
July 1st 2013Dr. Derm has a large dermatology practice with eight employee dermatologists. Each employee physician has signed an agreement that stipulates his/her duties, salary and benefits. Each agreement also has a restrictive covenant that states that if the employee physician chooses to leave, he/she cannot practice within 10 miles for two years after the separation from Dr. Derm’s practice.
Targeted therapy, immunotherapy tackle metastatic melanoma
July 1st 2013There has been a rapid revolution in the treatment of metastatic melanoma since the identification of driver oncogenes such as BRAF and its mutations more than a decade ago, according to a clinical researcher at the Vanderbilt-Ingram Cancer Center, Nashville, Tenn.